Selected Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2020

Selected Quarterly Financial Data (Unaudited)

Summary of unaudited quarterly results of operations

	For the Quarter Ended
	March 31,		June 30,		September 30,		December 31,
	2019		2019		2019		2019
Year Ended December 31, 2019
Net revenue:
Managed care and other	$	566,548	$	608,614	$	591,229	$	580,544
PBM and dispensing		552,458		545,675		567,314		553,231
Total net revenue		1,119,006		1,154,289		1,158,543		1,133,775
Costs and expenses:
Cost of care		369,097		408,911		397,697		367,819
Cost of goods sold		526,314		501,081		523,973		507,917
Direct service costs and other operating expenses (1)		202,300		195,907		195,844		207,616
Depreciation and amortization		25,417		28,191		28,890		27,869
Interest expense		9,037		9,070		8,935		8,826
Interest and other income		(1,759)		(1,821)		(1,699)		(1,578)
Special charges		—		—		—		—
Total costs and expenses		1,130,406		1,141,339		1,153,640		1,118,469
Income (loss) from continuing operations before income taxes		(11,400)		12,950		4,903		15,306
Provision (benefit) for income taxes		(3,209)		5,735		782		5,854
Net income (loss) from continuing operations		(8,191)		7,215		4,121		9,452
Income from discontinued operations, net of tax		8,622		6,398		17,153		11,132
Net Income	$	431	$	13,613	$	21,274	$	20,584
Weighted average number of common shares outstanding—basic		23,946		24,101		24,426		24,491
Weighted average number of common shares outstanding—diluted		24,213		24,416		24,708		24,905
Net income (loss) per common share—basic:
Continuing operations	$	(0.34)	$	0.30	$	0.17	$	0.39
Discontinued operations		0.36		0.26		0.70		0.45
Consolidated operations	$	0.02	$	0.56	$	0.87	$	0.84
Net income (loss) per common share—diluted:
Continuing operations	$	(0.34)	$	0.30	$	0.17	$	0.38
Discontinued operations		0.36		0.26		0.69		0.45
Consolidated operations	$	0.02	$	0.56	$	0.86	$	0.83

	For the Quarter Ended
	March 31,		June 30,		September 30,		December 31,
	2020		2020		2020		2020
Year Ended December 31, 2020
Net revenue:
Managed care and other	$	553,168	$	548,711	$	568,688	$	579,454
PBM and dispensing		569,211		551,364		601,429		605,506
Total net revenue		1,122,379		1,100,075		1,170,117		1,184,960
Costs and expenses:
Cost of care		349,108		321,831		364,438		362,478
Cost of goods sold		533,241		528,067		560,269		559,140
Direct service costs and other operating expenses (2)		204,241		199,756		216,770		259,401
Depreciation and amortization		23,358		23,888		24,730		26,411
Interest expense		8,958		7,995		7,286		6,626
Interest and other income		(1,219)		(551)		(349)		(1,935)
Special charges		—		8,309		16,599		9,170
Total costs and expenses		1,117,687		1,089,295		1,189,743		1,221,291
Income (loss) from continuing operations before income taxes		4,692		10,780		(19,626)		(36,331)
Provision (benefit) for income taxes		5,762		(36,328)		(2,330)		(11,635)
Net income (loss) from continuing operations		(1,070)		47,108		(17,296)		(24,696)
Income from discontinued operations, net of tax		19,320		36,397		28,943		293,629
Net Income	$	18,250	$	83,505	$	11,647	$	268,933
								.
Weighted average number of common shares outstanding—basic		24,728		25,054		25,448		25,781
Weighted average number of common shares outstanding—diluted		24,869		25,278		25,448		25,781
Net income (loss) per common share—basic:
Continuing operations	$	(0.04)	$	1.88	$	(0.68)	$	(0.96)
Discontinued operations		0.78		1.45		1.14		11.39
Consolidated operations	$	0.74	$	3.33	$	0.46	$	10.43
Net income (loss) per common share—diluted:
Continuing operations	$	(0.04)	$	1.86	$	(0.68)	$	(0.96)
Discontinued operations		0.78		1.44		1.14		11.39
Consolidated operations	$	0.74	$	3.30	$	0.46	$	10.43

(1) Includes stock compensation expense of $9,400, $5,207, $4,604 and $5,462 for the quarters ended March 31, June 30, September 30 and December 31, 2019, respectively.

(2) Includes stock compensation expense of $5,797, $6,592, $5,442 and $7,341 for the quarters ended March 31, June 30, September 30 and December 31, 2020, respectively.